Mapping human disease-associated enzymes into Reactome allows characterization of disease groups and their interactions.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 10 2022
26 10 2022
Historique:
received:
22
07
2022
accepted:
19
10
2022
entrez:
26
10
2022
pubmed:
27
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
According to databases such as OMIM, Humsavar, Clinvar and Monarch, 1494 human enzymes are presently associated to 2539 genetic diseases, 75% of which are rare (with an Orphanet code). The Mondo ontology initiative allows a standardization of the disease name into specific codes, making it possible a computational association between genes, variants, diseases, and their effects on biological processes. Here, we tackle the problem of which biological processes enzymes can affect when the protein variant is disease-associated. We adopt Reactome to describe human biological processes, and by mapping disease-associated enzymes in the Reactome pathways, we establish a Reactome-disease association. This allows a novel categorization of human monogenic and polygenic diseases based on Reactome pathways and reactions. Our analysis aims at dissecting the complexity of the human genetic disease universe, highlighting all the possible links within diseases and Reactome pathways. The novel mapping helps understanding the biochemical/molecular biology of the disease and allows a direct glimpse on the present knowledge of other molecules involved. This is useful for a complete overview of the disease molecular mechanism/s and for planning future investigations. Data are collected in DAR, a database that is free for search and available at https://dar.biocomp.unibo.it .
Identifiants
pubmed: 36289281
doi: 10.1038/s41598-022-22818-5
pii: 10.1038/s41598-022-22818-5
pmc: PMC9605996
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17963Informations de copyright
© 2022. The Author(s).
Références
Curr Med Chem. 2022;29(3):489-525
pubmed: 34042028
Int J Mol Sci. 2022 May 14;23(10):
pubmed: 35628319
Sci Transl Med. 2016 Mar 2;8(328):328ra30
pubmed: 26936507
Mol Cytogenet. 2019 Feb 04;12:4
pubmed: 30766616
Orphanet J Rare Dis. 2020 Jan 29;15(1):31
pubmed: 31996241
Biochimie. 2021 Jan;180:104-120
pubmed: 33164889
J Comorb. 2018 Oct 23;8(1):2235042X18806986
pubmed: 30364915
J Clin Med. 2022 May 27;11(11):
pubmed: 35683414
Nucleic Acids Res. 2022 Jan 7;50(D1):D687-D692
pubmed: 34788843
Endocr Rev. 2022 Jan 12;43(1):61-90
pubmed: 34007986
Gene. 2021 Dec 15;804:145894
pubmed: 34418469
Nat Rev Genet. 2016 Oct;17(10):615-29
pubmed: 27498692
Cell Metab. 2017 Jan 10;25(1):27-42
pubmed: 27641100
J Inherit Metab Dis. 2019 Jul;42(4):673-685
pubmed: 30693532
Int J Dermatol. 2015 Feb;54(2):121-9
pubmed: 25521013
Scientifica (Cairo). 2016;2016:9828672
pubmed: 27051561
Nat Commun. 2014 Jun 26;5:4212
pubmed: 24967666
Nat Commun. 2021 Nov 9;12(1):6306
pubmed: 34753928